Experience

The OCT team has been conducting clinical trials since 2005. We are actively leading projects in Russia, CIS countries and Europe, providing support to our clients from the research planning stage up to drug registration.


Since 2005, OCT has been involved in more than 300 full-service and functional service projects. Such vast experience allows us to assess potential risks and be able to prevent them at the first stage of project planning.


We are always available to provide more information about our experience and discuss, in detail, your next clinical trial in detail.





Therapeutic area experience





Detailed study list see below:



Indications Phase Year
Open Angle Glaucoma III 2019
Cirrosis II 2019
NA, Healthy volunteers BE study 2019
Treatment of nasolabial folds IV 2019
Influenza III 2019
Acute respiratory viral infection III 2019
NA, Healthy volunteers BE study 2019
Chronic Myeloid Lymphoma III 2019
Lower back pain II 2019
NA, Healthy volunteers I 2019
Helicobacter pylori infection n/a 2019
Breast Cancer III 2019
NA, Healthy volunteers BE study 2019
Chron's disease III 2019
Osteoarthritis III 2019
Preclinical Pre-clinical 2019
Ocular infection partial service 2019
Open Angle Glaucoma III 2018
Moderate to Severe Glabellar Lines III 2018
Ulcerative Сolitis III 2018
Tuberculosis I 2018
Ocular diseases partial service 2018
Pain I 2018
Non-small-cell lung carcinoma I 2018
Acute Hemorrhoids III 2018
Acute hemorrhoids III 2018
Ischemic heart disease partial service 2018
Influenza vaccine partial service 2018
Functional dyspepsia III 2018
Back pain III 2018
Helicobacter pylori infection partial service 2018
Thrombosis prevention II 2018
Erectile Dysfunction III 2018
Influenza III 2018
Influenza III 2018
Ocular infection partial service 2018
Ocular infection partial service 2018
Traumatic brain injury III 2018
Kidney failure partial service 2018
Influenza III 2018
Ocular infection partial service 2018
Ocular infection partial service 2018
Nausea and vomiting partial service 2018
Influenza partial service 2018
Influenza vaccine partial service 2018
Uterine fibroid II 2018
Allergic rhinitis BE study 2018
Validation study of a dietary assessment instrument partial service 2018
Astenospermia II 2017
Hematology oncology II 2017
Hematology oncology II 2017
Osteoarthritis IV 2017
Hematology oncology II 2017
HIV BE study 2017
Influenza vaccine I 2017
Tuberculosis II 2017
Lower limb ischemia II 2017
Parenteral Nutrition III 2017
Breast Cancer partial service 2017
Influenza vaccine III 2017
Seborrheic dermatitis III 2017
Pain III 2017
Chronic cerebral ischemia partial service 2017
Influenza vaccine I 2017
Acute diarrhea III 2017
Type I Diabetes Mellitus partial service 2017
Ulcerative Colitis I 2017
Osteoarthritis III 2017
Potassium deficiency partial service 2017
Rheumatoid Arthritis III 2017
Tuberculosis BE study 2017
Acute posthemorrhagic anemia II 2017
Sexual Dysfunction III 2017
Astenospermia III 2017
Tuberculosis II 2016
Rheumatoid Arthritis III 2016
B-cell Lymphomа II 2016
HIV BE study 2016
Rheumatoid Arthritis III 2016
Pain BE study 2016
HIV BE study 2016
Pain III 2016
B-Cell Lymphoma III 2016
Chronic Lymphoma III 2016
HIV BE study 2016
Rheumatoid Arthritis III 2016
HIV BE study 2016
Rheumatoid Arthritis I 2016
Analgesic I 2016
Breast Cancer I 2016
Acute Gout I 2016
Dry Eye syndrome III 2016
Stroke diagnostic test III 2016
Solid Tumors I 2016
Ulcerative proctitis III 2016
Pain III 2016
Breast Cancer III 2016
Hypertension BE study 2016
Erectile dysfunction BE study 2016
Hematology oncology BE study 2016
Kidney cancer BE study 2016
Breast Cancer III 2016
Back pain III 2016
Sexual Dysfunction I 2016
Preclinical partial service 2016
Preclinical partial service 2016
Parenteral Nutrition II 2015
Hemorrhoids I 2015
Breast Cancer III 2015
Chemotherapy-induced neutropenia I 2015
Colorectal Cancer III 2015
Chronic Blepharoconjunctivitis III 2015
Acute myeloid leucosis BE study 2015
Rheumatoid arthritis III 2015
Sexual dysfunction II 2015
Rheumatoid arthritis III 2015
Rheumatoid arthritis III 2015
Hepatic cirrhosis IV 2015
Hepatic cirrhosis IV 2015
Ph + CML I 2015
HIV Infection IV 2015
Vestibular Vertigo BE study 2015
Breast Cancer III 2015
AML III 2015
Tuberculosis I 2015
Hepatitis B III 2015
HIV Infection II 2015
HIV Infection II 2015
Astenospermia II 2015
Breast Cancer I 2015
Breast Cancer III 2015
Acute Viral Respiratory Infections II 2015
Mild cognitive impairment III 2015
Hepatocellular Carcinoma I 2015
Acute posthemorrhagic anemia I 2015
Pneumonia III 2015
Deep Vein Thrombosis III 2015
Lymphoma III 2015
Acromegaly IV 2015
BE study BE study 2015
Sexual dysfunction II 2015
BE study BE study 2015
Acute Otitis IV 2014
Advanced melanoma I 2014
Essential Arterial Hypertension III 2014
Metastatic Breast Cancer II 2014
Pre-clinical Pre-clinical 2014
Pre-clinical Pre-clinical 2014
Respiratory diseases I 2014
Respiratory Tract Infection IV 2014
Thoracic Aortic Aneurysm I 2014
Breast cancer I 2014
Chronic Obstructive Pulmonary Disease (COPD) II 2014
Complicated urinary tract infections III 2014
Corneal Injury I 2014
Diabetic Neuropathy III 2014
Healthy volunteers I 2014
Heart Failure III 2014
Infusion therapy III 2014
Schizophrenia II 2014
Schizophrenia III 2014
Schizophrenia II 2014
Solid tumors I 2014
Tuberculosis III 2014
Gerontology partial service 2014
Parenteral Nutrition III 2014
Advanced Melanoma I 2013
Aneurysmal Subarachnoid Hemorrhage I 2013
Aplastic Anemia IV 2013
Atherosclerosis II 2013
BE study BE study 2013
Breast Cancer IV 2013
Chronic Obstructive Pulmonary Disease IV 2013
Chronic Prostatitis IV 2013
Community Aquired Pneumonia III 2013
Type 2 Diabetes Mellitus IV 2013
Diarrhea IV 2013
Essential Hypertension III 2013
HBeAg Negative Chronic Hepatitis B virus infection II 2013
Hepatitis B I 2013
LV insufficiency IV 2013
Metastatic Cancer I 2013
Multiple Drug Resistant Tuberculosis IV 2013
Multiple Sclerosis III 2013
Non-small Cell Lung and Epithelial Ovarian Cancer I 2013
Non-small Cell Lung Cancer IV 2013
Community Aquired Pneumonia IV 2013
Ovarian Cancer I 2013
Parenteral Nutrition III 2013
Pre-clinical Pre-clinical 2013
Pregnancy Exposure IV 2013
Prophylaxis of thromboembolic complication in knee II 2013
Recurrent Upper Respiratory Tract Infections (RURTI) III 2013
Respiratory Tract Infection IV 2013
Rheumatoid Arthritis I 2013
Rheumatology III 2013
Schizophrenia II 2013
Solid Tumors I 2013
Sore throat III 2013
Thoracic Aortic Aneurysm I 2013
Type 2 Diabetes Mellitus III 2013
Vaginitis IV 2013
Acute Myeloid Leukemia II 2012
Advanced Melanoma I 2012
Atrial Fibrillation IV 2012
BE study BE study 2012
BE study BE study 2012
BE study BE study 2012
BE study BE study 2012
BE study BE study 2012
Breast Cancer II 2012
Chronic Hepatitis B II 2012
Chronic Kidney Disease III 2012
Coronary Artery Disease III 2012
Deep Vein Thrombosis III 2012
Dislipidemia I 2012
Hepatocellular Carcinoma partial service 2012
LV insufficiency IV 2012
Multiple Myeloma III 2012
Ocular Inflammation Following Cataract Surgery III 2012
Pain III 2012
Pre-clinical study Pre-clinical 2012
Sore Throat III 2012
Thromboembolitic Events IV 2012
Ulcerative Proctitis II 2012
Alcohol Abuse II 2011
Anxiety Disorder II 2011
Asthma III 2011
Back Pain III 2011
BE study BE study 2011
BE study BE study 2011
BE study BE study 2011
BE study BE study 2011
Biliary Colic III 2011
Bladder cancer II 2011
Breast Cancer II 2011
Central Catheter's Maintanance III 2011
Colorectal Cancer III 2011
Type 2 Diabetes Mellitus I 2011
Gout III 2011
Gynecology III 2011
Head and Neck Cancer III 2011
Intensive care III 2011
Ischemic Foot Ulcers III 2011
Isolated Systolic Hypertension III 2011
Locally Advanced Pancreatic Cancer II 2011
Multiple Myeloma III 2011
Multiple Sclerosis I 2011
Parenteral Nutrition III 2011
Pre-clinical Pre-clinical 2011
Pre-clinical Pre-clinical 2011
Pre-clinical Pre-clinical 2011
Rheumatoid Arthritis IV 2011
Solid Tumors I 2011
Solid Tumors I 2011
Stable Angina IV 2011
Toxicology Pre-clinical 2011
Wound healing, device II 2011
Sore Throat II 2010
Colorectal cancer III 2010
Colorectal Cancer II 2010
Endometrial Carcinoma II 2010
Intestinal colics IV 2010
Infant Colic II 2010
Liver disorder IV 2010
Major orthopedic surgery (pain model) III 2010
Mastocytosis II 2010
Metastatic Breast Cancer II 2010
Multiple Sclerosis IV 2010
Acute bronchitis IV 2010
Rhinnitis IV 2010
Solid Tumors II 2010
Colorectal anastomosis I 2010
Breast Cancer III 2009
Diabetes Mellitus II 2009
Erectile Dysfunction III 2009
Eradication of H. pylory II 2009
Hepatic cirrhosis III 2009
Hypothyreosis IV 2009
Breast Cancer II 2009
Bronchitis, pneumonia, AS IV 2009
Rheumatoid Arthritis II 2009
Age-related macular degeneration I 2008
Bone metastases, pain II 2008
Crohn's disease II 2008
Diabetes Mellitus II 2008
Brain Vessel Aneurism Rupture III 2008
Ovarian Cancer III 2008
Prostate cancer II 2008
Prostate cancer III 2008
Rheumatoid Arthritis II 2008
Solid Tumors I 2008
Acute Myeloid Leukosis partial service 2007
Acute Myocardial Infarction IV 2007
BE study BE study 2007
BE study BE study 2007
Breast Cancer II 2007
Breast Cancer II 2007
Breast Cancer, neutropenia III 2007
Hepatic metastases II 2007
Irritable Bowel Syndrome III 2007
Pain II 2007
Prostate cancer II 2007
Acne II 2006
Acute Heart Failure III 2006
Nutrition, pediatrics III 2006
Immunotherapy in Renal Cell Carcinoma III 2005
T-cell Leukemia II 2005
NA, Healthy volunteers I
Ocular infection partial service
Indications Phase Year
NA, Healthy volunteers BE study 2019
Validation study of a dietary assessment instrument partial service 2018
BE study BE study 2015
BE study BE study 2015
BE study BE study 2013
BE study BE study 2012
BE study BE study 2012
BE study BE study 2012
BE study BE study 2012
BE study BE study 2012
BE study BE study 2011
BE study BE study 2011
BE study BE study 2011
BE study BE study 2011
BE study BE study 2007
BE study BE study 2007
Indications Phase Year
Ischemic heart disease partial service 2018
Hypertension BE study 2016
Heart Failure III 2014
Thoracic Aortic Aneurysm I 2014
Essential Arterial Hypertension III 2014
Thoracic Aortic Aneurysm I 2013
LV insufficiency IV 2013
Essential Hypertension III 2013
Atherosclerosis II 2013
LV insufficiency IV 2012
Dislipidemia I 2012
Deep Vein Thrombosis III 2012
Coronary Artery Disease III 2012
Atrial Fibrillation IV 2012
Thromboembolitic Events IV 2012
Isolated Systolic Hypertension III 2011
Stable Angina IV 2011
Acute Myocardial Infarction IV 2007
Acute Heart Failure III 2006
Indications Phase Year
Pain III 2016
Indications Phase Year
Treatment of nasolabial folds IV 2019
Moderate to Severe Glabellar Lines III 2018
Seborrheic dermatitis III 2017
Ischemic Foot Ulcers III 2011
Acne II 2006
Indications Phase Year
Respiratory Tract Infection IV 2014
Acute Otitis IV 2014
Sore throat III 2013
Rhinnitis IV 2010
Indications Phase Year
Type I Diabetes Mellitus partial service 2017
Potassium deficiency partial service 2017
Acromegaly IV 2015
Diabetic Neuropathy III 2014
Type 2 Diabetes Mellitus III 2013
Type 2 Diabetes Mellitus IV 2013
Type 2 Diabetes Mellitus I 2011
Diabetes Mellitus II 2009
Hypothyreosis IV 2009
Diabetes Mellitus II 2008
Indications Phase Year
NA, Healthy volunteers I 2019
Helicobacter pylori infection n/a 2019
Chron's disease III 2019
Functional dyspepsia III 2018
Ulcerative Сolitis III 2018
Acute hemorrhoids III 2018
Acute Hemorrhoids III 2018
Helicobacter pylori infection partial service 2018
Ulcerative Colitis I 2017
Ulcerative proctitis III 2016
Hepatic cirrhosis IV 2015
Hepatic cirrhosis IV 2015
Ulcerative Proctitis II 2012
Biliary Colic III 2011
Liver disorder IV 2010
Intestinal colics IV 2010
Eradication of H. pylory II 2009
Hepatic cirrhosis III 2009
Crohn's disease II 2008
Irritable Bowel Syndrome III 2007
NA, Healthy volunteers I
Indications Phase Year
Gerontology partial service 2014
Indications Phase Year
NA, Healthy volunteers BE study 2019
NA, Healthy volunteers BE study 2019
Uterine fibroid II 2018
Sexual Dysfunction III 2017
Sexual dysfunction II 2015
Sexual dysfunction II 2015
Healthy volunteers I 2014
Vaginitis IV 2013
Gynecology III 2011
Indications Phase Year
Hematology oncology BE study 2016
AML III 2015
Ph + CML I 2015
Acute myeloid leucosis BE study 2015
Indications Phase Year
Cirrosis II 2019
HBeAg Negative Chronic Hepatitis B virus infection II 2013
Indications Phase Year
Allergic rhinitis BE study 2018
Indications Phase Year
Influenza III 2019
Acute respiratory viral infection III 2019
Tuberculosis I 2018
Influenza III 2018
Influenza III 2018
Influenza III 2018
Influenza vaccine partial service 2018
Influenza partial service 2018
Influenza vaccine partial service 2018
HIV BE study 2017
Tuberculosis II 2017
Tuberculosis BE study 2017
Influenza vaccine III 2017
Influenza vaccine I 2017
Tuberculosis II 2016
HIV BE study 2016
HIV BE study 2016
HIV BE study 2016
HIV BE study 2016
HIV Infection II 2015
HIV Infection II 2015
Hepatitis B III 2015
Tuberculosis I 2015
HIV Infection IV 2015
Acute Viral Respiratory Infections II 2015
Pneumonia III 2015
Tuberculosis III 2014
Complicated urinary tract infections III 2014
Respiratory Tract Infection IV 2014
Recurrent Upper Respiratory Tract Infections (RURTI) III 2013
Respiratory Tract Infection IV 2013
Multiple Drug Resistant Tuberculosis IV 2013
Hepatitis B I 2013
HBeAg Negative Chronic Hepatitis B virus infection II 2013
Chronic Hepatitis B II 2012
Acute bronchitis IV 2010
Bronchitis, pneumonia, AS IV 2009
Indications Phase Year
Osteoarthritis IV 2017
Pain BE study 2016
Pain III 2016
Analgesic I 2016
Back pain III 2016
Diarrhea IV 2013
Aplastic Anemia IV 2013
Pain III 2012
Intensive care III 2011
Parenteral Nutrition III 2011
Mastocytosis II 2010
Indications Phase Year
Stroke diagnostic test III 2016
Indications Phase Year
Kidney failure partial service 2018
Chronic Kidney Disease III 2012
Indications Phase Year
Lower back pain II 2019
Pain I 2018
Back pain III 2018
Traumatic brain injury III 2018
Nausea and vomiting partial service 2018
Pain III 2017
Chronic cerebral ischemia partial service 2017
Pain BE study 2016
Stroke diagnostic test III 2016
Mild cognitive impairment III 2015
Vestibular Vertigo BE study 2015
Pregnancy Exposure IV 2013
Multiple Sclerosis III 2013
Aneurysmal Subarachnoid Hemorrhage I 2013
Multiple Sclerosis I 2011
Back Pain III 2011
Multiple Sclerosis IV 2010
Brain Vessel Aneurism Rupture III 2008
Indications Phase Year
Chronic Myeloid Lymphoma III 2019
Breast Cancer III 2019
Non-small-cell lung carcinoma I 2018
Hematology oncology II 2017
Hematology oncology II 2017
Hematology oncology II 2017
Breast Cancer partial service 2017
B-cell Lymphomа II 2016
B-Cell Lymphoma III 2016
Chronic Lymphoma III 2016
Breast Cancer I 2016
Solid Tumors I 2016
Breast Cancer III 2016
Hematology oncology BE study 2016
Kidney cancer BE study 2016
Breast Cancer III 2016
Lymphoma III 2015
Breast Cancer III 2015
Breast Cancer III 2015
Breast Cancer III 2015
Breast Cancer I 2015
AML III 2015
Ph + CML I 2015
Colorectal Cancer III 2015
Chemotherapy-induced neutropenia I 2015
Acute myeloid leucosis BE study 2015
Hepatocellular Carcinoma I 2015
Solid tumors I 2014
Breast cancer I 2014
Metastatic Breast Cancer II 2014
Advanced melanoma I 2014
Solid Tumors I 2013
Ovarian Cancer I 2013
Non-small Cell Lung Cancer IV 2013
Metastatic Cancer I 2013
Breast Cancer IV 2013
Non-small Cell Lung and Epithelial Ovarian Cancer I 2013
Advanced Melanoma I 2013
Multiple Myeloma III 2012
Breast Cancer II 2012
Advanced Melanoma I 2012
Acute Myeloid Leukemia II 2012
Hepatocellular Carcinoma partial service 2012
Solid Tumors I 2011
Solid Tumors I 2011
Multiple Myeloma III 2011
Head and Neck Cancer III 2011
Colorectal Cancer III 2011
Breast Cancer II 2011
Bladder cancer II 2011
Locally Advanced Pancreatic Cancer II 2011
Solid Tumors II 2010
Metastatic Breast Cancer II 2010
Endometrial Carcinoma II 2010
Colorectal Cancer II 2010
Colorectal cancer III 2010
Breast Cancer II 2009
Breast Cancer III 2009
Solid Tumors I 2008
Prostate cancer III 2008
Prostate cancer II 2008
Ovarian Cancer III 2008
Bone metastases, pain II 2008
Prostate cancer II 2007
Breast Cancer, neutropenia III 2007
Breast Cancer II 2007
Breast Cancer II 2007
Pain II 2007
Hepatic metastases II 2007
Acute Myeloid Leukosis partial service 2007
T-cell Leukemia II 2005
Immunotherapy in Renal Cell Carcinoma III 2005
Indications Phase Year
Open Angle Glaucoma III 2019
Ocular infection partial service 2019
Open Angle Glaucoma III 2018
Ocular diseases partial service 2018
Ocular infection partial service 2018
Ocular infection partial service 2018
Ocular infection partial service 2018
Ocular infection partial service 2018
Dry Eye syndrome III 2016
Chronic Blepharoconjunctivitis III 2015
Corneal Injury I 2014
Ocular Inflammation Following Cataract Surgery III 2012
Age-related macular degeneration I 2008
Ocular infection partial service
Indications Phase Year
Acute diarrhea III 2017
Parenteral Nutrition III 2014
Recurrent Upper Respiratory Tract Infections (RURTI) III 2013
Acute bronchitis IV 2010
Infant Colic II 2010
Intestinal colics IV 2010
Bronchitis, pneumonia, AS IV 2009
Nutrition, pediatrics III 2006
Indications Phase Year
Preclinical Pre-clinical 2019
Preclinical partial service 2016
Preclinical partial service 2016
Pre-clinical Pre-clinical 2014
Pre-clinical Pre-clinical 2013
Pre-clinical study Pre-clinical 2012
Toxicology Pre-clinical 2011
Pre-clinical Pre-clinical 2011
Pre-clinical Pre-clinical 2011
Pre-clinical Pre-clinical 2011
Indications Phase Year
Ulcerative proctitis III 2016
Indications Phase Year
Sexual Dysfunction III 2017
Sexual dysfunction II 2015
Sexual dysfunction II 2015
Schizophrenia II 2014
Schizophrenia III 2014
Schizophrenia II 2014
Schizophrenia II 2013
Anxiety Disorder II 2011
Alcohol Abuse II 2011
Indications Phase Year
Influenza vaccine I 2017
Acute Viral Respiratory Infections II 2015
Pneumonia III 2015
Chronic Obstructive Pulmonary Disease (COPD) II 2014
Respiratory diseases I 2014
Pre-clinical Pre-clinical 2014
Recurrent Upper Respiratory Tract Infections (RURTI) III 2013
Respiratory Tract Infection IV 2013
Community Aquired Pneumonia IV 2013
Community Aquired Pneumonia III 2013
Chronic Obstructive Pulmonary Disease IV 2013
Sore Throat III 2012
Asthma III 2011
Acute bronchitis IV 2010
Sore Throat II 2010
Bronchitis, pneumonia, AS IV 2009
Indications Phase Year
Osteoarthritis III 2019
Osteoarthritis III 2017
Rheumatoid Arthritis III 2017
Rheumatoid Arthritis III 2016
Rheumatoid Arthritis III 2016
Rheumatoid Arthritis III 2016
Rheumatoid Arthritis I 2016
Acute Gout I 2016
Rheumatoid arthritis III 2015
Rheumatoid arthritis III 2015
Rheumatoid arthritis III 2015
Rheumatology III 2013
Rheumatoid Arthritis I 2013
Rheumatoid Arthritis IV 2011
Gout III 2011
Rheumatoid Arthritis II 2009
Rheumatoid Arthritis II 2008
Indications Phase Year
Thrombosis prevention II 2018
Acute posthemorrhagic anemia II 2017
Parenteral Nutrition III 2017
Acute posthemorrhagic anemia I 2015
Parenteral Nutrition II 2015
Hemorrhoids I 2015
Infusion therapy III 2014
Thoracic Aortic Aneurysm I 2014
Thoracic Aortic Aneurysm I 2013
Prophylaxis of thromboembolic complication in knee II 2013
Parenteral Nutrition III 2013
Wound healing, device II 2011
Central Catheter's Maintanance III 2011
Major orthopedic surgery (pain model) III 2010
Colorectal anastomosis I 2010
Indications Phase Year
Erectile Dysfunction III 2018
Astenospermia II 2017
Astenospermia III 2017
Erectile dysfunction BE study 2016
Kidney cancer BE study 2016
Sexual Dysfunction I 2016
Sexual dysfunction II 2015
Astenospermia II 2015
Complicated urinary tract infections III 2014
Chronic Prostatitis IV 2013
Erectile Dysfunction III 2009
Indications Phase Year
Lower limb ischemia II 2017
Stroke diagnostic test III 2016
Hypertension BE study 2016
Deep Vein Thrombosis III 2015
Thoracic Aortic Aneurysm I 2014
Thoracic Aortic Aneurysm I 2013
Deep Vein Thrombosis III 2012